Avita Medical | 1811094D - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Accuray USD 124.78M 2.54M 2025-12
Celltrion KRW 12.72B 3.4B 2026-06
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Kangmei Pharma CNY 253.72M 16.66M 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 54.8M 11.94M 2024-06
Medical Developments International AUD 2.84M 4.19M 2025-12
Nanosonics AUD 53.78M 26.93M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 26.51M 4.5M 2026-06
Ovoca Bio EUR 617K 15K 2025-12
Pacific Edge NZD 16.75M 2.42M 2026-06
Pharma Mar EUR 15.53M 1.59M 2026-09
Polynovo AUD 17.04M 1.91M 2025-12
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Qiagen NV USD 142.33M 60K 2026-06
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 296.28M 10.63M 2026-06
Sartorius EUR 216.6M 4.7M 2026-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Telix Pharmaceuticals AUD 107.02M 13.54M 2026-06
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 267.85M 44.71M 2026-09